DEF 14AThe Ballot
Kymera Therapeutics, Inc. files DEF 14A
Filed Apr 29, 2025 · 1y ago · Accession 0001193125-25-103767
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Kymera Therapeutics, Inc.
- Ticker
- KYMR
- CIK
- 1815442
- Form type
- DEF 14A
- Filing date
- Apr 29, 2025
- Report date
- Jun 25, 2025
- Document
- d922602ddef14a.htm
- Size
- 1.9 MB